For the Right Perspective & Competitive Insights. Make confident decisions using our benchmarks and analysis.
Download FREE Sample Report
Read the 120-page report with TOC on "Laryngeal Cancer Therapeutics Market Analysis Report by Type (Biologics and Small molecules) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2021-2025". Gain competitive intelligence about market leaders. Track key industry opportunities, trends, and threats. Information on marketing, brand, strategy and market development, sales and supply functions.
More Details: https://www.technavio.com/report/report/laryngeal-cancer-therapeutics-market-industry-analysis
The laryngeal cancer therapeutics market is driven by the increasing prevalence of laryngeal cancer. In addition, the increasing number of reimbursement programs is anticipated to boost the growth of the laryngeal cancer therapeutics market.
The increasing risk factors and increasing use of tobacco products for laryngeal cancer are some of the major drivers of the global laryngeal cancer therapeutics market. Smoking and consumption of tobacco products are known to be the causes of approximately 75% of laryngeal cancer cases. The high mortality rate and the prevalence of the indication are leading to an increase in the use of therapeutics such as chemotherapy and targeted therapy for the treatment. Also, factors such as the increasing incidence of HPV-caused cancers are driving the growth of the market due to the metastatic nature of the virus. Hence, the global laryngeal cancer therapeutics market is expected to benefit from the increasing prevalence of the indication during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Laryngeal Cancer Therapeutics Companies:
Amgen Inc.
Amgen Inc. operates business through the Unified segment. The company provides Vectibix (panitumumab) as a first-line treatment to patients with recurrent and/or metastatic squamous cell head and neck cancer.
AstraZeneca Plc
AstraZeneca Plc operates business through the Unified segment. The company provides early treatment for Laryngeal cancer by seeking to combat metastatic and resistant disease, exploring ctDNA, and by defining new biomarkers and therapeutic targets.
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co. operates business through the Unified segment. The company provides Opdivo (nivolumab) injection, for intravenous use, for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck cancer.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates business through Pharmaceuticals and Diagnostics. The company provides XELODA, TECENTRIQ, and AVASTIN medicines to treat laryngeal cancer.
Merck & Co. Inc.
Merck & Co. Inc. operates business through Pharmaceuticals, Animal health, and Others. The company provides KEYTRUDA which is a medicine used in the treatment of head and neck squamous cell cancer.
Laryngeal Cancer Therapeutics Market Type Outlook (Revenue, USD million, 2020-2025)
- Biologics - size and forecast 2020-2025
- Small molecules - size and forecast 2020-2025
Laryngeal Cancer Therapeutics Market Geography Outlook (Revenue, USD million, 2020-2025)
- North America - size and forecast 2020-2025
- Europe - size and forecast 2020-2025
- Asia - size and forecast 2020-2025
- ROW - size and forecast 2020-2025
Are you a start-up willing to make it big in the business? Download FREE Sample Report
Related Reports on Health Care Include:
Global Alcoholic Hepatitis Treatment Market- The alcoholic hepatitis treatment market is segmented by type (corticosteroids, xanthine derivatives, and others), geography (North America, Europe, Asia, and ROW), and key vendors.
To get extensive research insights: Get an Exclusive Free Sample Report in Minutes
Global Mycosis Fungoides Therapeutics Market- The mycosis fungoides therapeutics market is segmented by type (small molecules and biologics), geography (North America, Europe, Asia, and ROW), and key vendors.
To get extensive research insights: Get an Exclusive Free Sample Report in Minutes
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report Page: https://www.technavio.com/report/laryngeal-cancer-therapeutics-market-industry-analysis
SOURCE Technavio
Related Links
http://www.technavio.com/
Share this article